We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
Turnover
53.18%
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.17%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$36.8M
AUM Growth
+$8.2M
(+29%)
Cap. Flow
+$3.54M
Cap. Flow
% of AUM
9.62%
Top 10 Holdings %
Top 10 Hldgs %
35.87%
Holding
81
New
27
Increased
10
Reduced
15
Closed
16
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$1.46M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$1.44M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.42M |
| 4 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
+$1.05M |
| 5 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$807K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.31M |
| 2 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
+$2.05M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$872K |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$810K |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$755K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.44% |
| 2 | Miscellaneous | 30.67% |
| 3 | Financials | 12.52% |
| 4 | Technology | 8.03% |
| 5 | Communication Services | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KDMN
1
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.75M | 4.75% |
342,000
-44,600
| -12% | -$200K |
2016 Q4
14 quarters
|
|
|
ETFC
2
DELISTED
E*Trade Financial Corporation
ETFC
| $1.69M | 4.59% |
+34,000
| New | +$1.46M |
2020 Q2
0 quarters
|
|
|
BLPH
3
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $1.57M | 4.26% |
125,000
+75,000
| +150% | +$1.05M |
2019 Q1
5 quarters
|
|
|
4
Regeneron Pharmaceuticals
REGN
$82.4B
| $1.56M | 4.23% |
+2,500
| New | +$1.42M |
2020 Q2
0 quarters
|
|
|
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.49M | 4.04% |
5,167
+455
| +10% | +$134K |
2018 Q2
8 quarters
|
|
|
6
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $1.41M | 3.83% |
+50,000
| New | +$1.44M |
2020 Q2
0 quarters
|
|
7
DELISTED
Affimed
AFMD
| $1.06M | 2.87% |
22,927
-9,450
| -29% | -$263K |
2015 Q2
20 quarters
|
|
|
ACIA
8
DELISTED
Acacia Communications Inc
ACIA
| $941K | 2.56% |
14,000
+4,000
| +40% | +$271K |
2019 Q3
3 quarters
|
|
|
9
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.16B
| $888K | 2.41% |
+25,000
| New | +$807K |
2020 Q2
0 quarters
|
|
10
iShares MSCI Europe Financials ETF
EUFN
$3.65B
| $854K | 2.32% |
+60,000
| New | +$794K |
2020 Q2
0 quarters
|
|
11
Bank of America
BAC
$363B
| $845K | 2.29% |
35,582
+20,582
| +137% | +$486K |
2020 Q1
1 quarter
|
|
12
ADMA Biologics
ADMA
$2.4B
| $821K | 2.23% |
280,141
-10,620
| -4% | -$30.5K |
2019 Q2
4 quarters
|
|
13
DELISTED
El Paso Electric Company
EE
| $784K | 2.13% |
+11,700
| New | +$792K |
2020 Q2
0 quarters
|
|
14
CALL
Walt Disney
DIS
$192B
| $769K | 2.09% |
6,900
| – | – |
2020 Q1
1 quarter
|
|
|
15
Walt Disney
DIS
$192B
| $769K | 2.09% |
6,900
| – | – |
2020 Q1
1 quarter
|
|
|
16
PUT
Walt Disney
DIS
$192B
| $769K | 2.09% |
6,900
| – | – |
2020 Q1
1 quarter
|
|
17
Aclaris Therapeutics
ACRS
$508M
| $768K | 2.09% |
473,915
-27,085
| -5% | -$36.3K |
2018 Q1
9 quarters
|
|
|
DLPH
18
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $760K | 2.06% |
+53,500
| New | +$600K |
2020 Q2
0 quarters
|
|
19
SPDR Gold Trust
GLD
$141B
| $753K | 2.04% |
4,500
| – | – |
2017 Q3
11 quarters
|
|
|
FIT
20
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $752K | 2.04% |
116,400
+16,400
| +16% | +$107K |
2019 Q4
2 quarters
|
|
|
LM
21
DELISTED
Legg Mason, Inc.
LM
| $735K | 2% |
+14,769
| New | +$733K |
2020 Q2
0 quarters
|
|
22
Mustang Bio
MBIO
$2.88M
| $729K | 1.98% |
306
+230
| +303% | +$538K |
2020 Q1
1 quarter
|
|
23
ExxonMobil
XOM
$717B
| $729K | 1.98% |
16,298
+98
| +0.6% | +$4.39K |
2020 Q1
1 quarter
|
|
|
24
CALL
ExxonMobil
XOM
$717B
| $724K | 1.97% |
16,200
| – | – |
2020 Q1
1 quarter
|
|
|
25
PUT
ExxonMobil
XOM
$717B
| $724K | 1.97% |
16,200
| – | – |
2020 Q1
1 quarter
|
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Telemetry Investments held 81 positions worth $36.8M, up 29% from $28.6M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Telemetry Investments deployed $3.54M of net new capital in Q2 2020, opening 27 new positions and adding to 10 existing holdings. Its largest new stake was E*Trade Financial Corporation: 34,000 shares worth $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 47% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Zosano Pharma Corporation, an estimated $2.05M trimmed.
- Telemetry Investments's largest Q2 2020 buy was E*Trade Financial Corporation: 34,000 shares worth $1.69M.
- Telemetry Investments added most to Bellerophon Therapeutics, Inc. in Q2 2020, an estimated $1.05M increase.
- Telemetry Investments's biggest Q2 2020 reduction was Zosano Pharma Corporation, cutting an estimated $2.05M.
- Telemetry Investments fully exited Allergan plc in Q2 2020, selling an estimated $3.31M.
- Telemetry Investments's ten largest holdings make up 36% of its $36.8M portfolio in Q2 2020.
- Telemetry Investments opened 27 new positions and closed 16 in Q2 2020.
- Telemetry Investments's portfolio value rose 29% quarter-over-quarter to $36.8M.
Based on Telemetry Investments's 13F filing for Q2 2020, filed 14 Aug 2020.